3. Acute Urinary Retention
3/28/2014AUR seminar3
ī Definition:- Painful inability to void, with relief of
pain following drainage of the bladder by
catheterization.
4. Pathophysiologic mechanism of AUR
3/28/2014AUR seminar4
ī1. BOO( bladder out flow
obstruction)
ī Out flow obstruction by
A) Mechanical :-
ī physical narrowing of the urethral channel
ī related to the volume of the prostate gland , other
mass, or stricture.
B) Dynamic obstruction:-
ī refers to the tension within and around the urethra.
ī When obstruction is caused by BPH,
ī dynamic obstruction is caused by the prostate
capsular tone and smooth muscle tone within the
prostate gland itself.
ī Medications and other factors also play a role in
selected patients.
5. Pathophysiologic contndâĻ..
3/28/2014AUR seminar5
ī 2) Neurologic impairment
ī Occur due to interruption of sensory or motor
nerve supply to the detrusor muscle.
ī This is most commonly seen in spinal cord
injuries, progressive neurologic diseases, diabetic
neuropathy, and cerebrovascular accidents
ī Less common, but important, neurologic causes
include epidural abscess and epidural metastasis,
that can compress the spinal cord and thereby
cause urinary retention as well as back pain and
lower extremity neurologic impairments
6. Pathophysiologic contndâĻ..
3/28/2014AUR seminar6
ī 3). Over distention
ī Acute urinary retention may result when a
precipitating event results in an acute distended
bladder in the setting of an inefficient detrusor
muscle
ī This most often occurs in patients with obstructive
urinary symptoms at baseline, who are then
subjected to an insult to the lower urinary tract,
ī such as a fluid challenge (eg, alcohol,
intravenous hydration), bladder distention during
general anesthesia, or epidural analgesia without
an indwelling Foley catheter.
7. 3/28/2014AUR seminar7
ī Medications â Multiple medications are
implicated in the cause of urinary retention,
principally involving anticholinergic and
sympathomimetic drugs
ī Pharmacologic agents associated with urinary
retention.docx
8. RISK FACTORS
3/28/2014AUR seminar8
ī Age â Age over 70 years
ī Symptom score â Use of the AUA symptom
score (IPSS) permits quantitation of symptom
severity and monitoring of symptom progression
over time .
ī Prostate volume â Prostatic volumes greater
than 30 mL as measured by trans rectal
ultrasound have been associated with AUR
ī Urinary flow rate â Urinary flow rate of less than
12 mL/sec carries an RR of 3.9.
10. 3/28/2014AUR seminar10
ī AUR may also be related to a variety of other
factors
ī Malignancy â bladder neoplasm, other tumors
causing spinal cord compression
ī Phimosis or paraphimosis, which is prolonged
foreskin retraction with swelling of the glans
constricting the foreskin
12. Causes of AUR
3/28/2014AUR seminar12
ī 1) Urethral Stricture
ī common in men with most patients acquiring the
disease due to injury or infection
ī The most common etiology for stricture is
iatrogenic injury due to urologic instrumentation
(eg, oversized resect scope or the placement of
indwelling catheters.
14. Urethral Injury
urethrography
ī Posterior urethra
īŧ Nearly always ass. With pelvic #
īŧ Crush, blunt, penetr. Or iatrogenic
īŧ Associated bladder inj.
ī Blood at meatus
ī Failure to void
ī Full bladder
ī Perineal swelling
ī Displaced prostate- DRE
3/28/2014AUR seminar14
15. UrethralâĻ
3/28/2014AUR seminar15
ī Classes of injury
īŧ Complete or partial
īŧ Difficult to say which
īŧ Further classes based on radiograph
ī Management (Immediate)
īŧ Stretch
- indwelling cath until able to void
īŧ Partial tear âcareful! attempt
- SPC then voiding CUG
21. 3/28/2014AUR seminar21
ī Diagnosis
ī Urethroscopy
ī Urethrography
ī Treatment
ī Dilation with elastic or metallic boogie Urethrotomy ,
internal visual incision of stricture
ī Urethroplasty, Excision and end to end anastomosis,
patch urethroplasty
24. BPH
3/28/2014AUR seminar24
ī BPH occurs in men over 50 years of age;
ī By the age of 60 years
ī 50 per cent of men have histological evidence of
BPH and
ī 15 per cent have significant lower urinary tract
symptoms
25. 3/28/2014AUR seminar25
Etiology
īļ Unknown
īļ Aging
īļ Hormonal effects
īŧAndrogen is important for both normal & abnormal
growth of the prostate
īŧ90% of prostatic androgen is in form of DHT( from
testicular androgen & 10% from adrenal androgen)
īŧStromal â epithelial cells interaction produce growth
factors (epidermal GF, insulin like GF,fibroblast GF)
īŧIncreased estrogen increase the expression of AR in
aging prostate & increase prostate size
26. Pathogenesis
(Gland Enlargement)
3/28/2014AUR seminar26
ī Occurs as results of increased Number of epithelial
& stromal cell ( increased cell proliferation)
ī Disruption of equilibrium between cell death & cell
proliferation(decreased in cell death)
ī Androgen requiring during development, puberty,&
aging
ī Castrated men or no androgen results no BPH
27. 3/28/2014AUR seminar27
Common symptoms
(symtomatology)
ī§ Prostatism =LUTS
ī§ Classified in to irritative
īą obstructive frequency
īŧ Weak urine stream urgency
īŧ Difficulty starting urination urge incontinency
īŧ Dribbling enuresis
īŧ Needing to urinate several times
īŧ Straining
īŧ Sensation poor bladder emptying
28. SymptomatologyâĻâĻ
3/28/2014AUR seminar28
ī Scoring system IPSS
AUA
ī Used for assessment of symptom severity
ī Assess the response to therapy
ī Detect symptom progression ( in watchful waiting Rx)
ī Can not used to establish the DX of
BPH(infections,tumor ,bladder disease will have a
high ipss)
ī According to IPSS
ī 0-9 mildly symptomatic
ī 8-19 moderately symptomatic
ī 20-35 severely symptomatic
30. DDX of BOO
3/28/2014AUR seminar30
ī BPH
ī BNC
ī Bladder stone
ī Urethral stricture
ī Prostatic cancer
ī Neurogenic bladder
31. Diagnosis of BPH
3/28/2014AUR seminar31
ī To pathologist is microscopic Dx(cellular
proliferation of stomal & epithelial elements)
ī To radiologist makes the Dx in presence of
bladder neck elevation of cystogram phase of
IVP or enlarged prostate
ī To urodynamist -elevated voiding pressure
-low urinary rate
ī To practicing urologist is constellation of sign &
symptom
32. DiagnosisâĻ..
ī Hx
ī onset of the symptoms
ī Age
ī Hx of STD
ī Determine which symptoms are predominant(
irritative or obstructive)
ī Determine severity of the symptoms by IPSS)
ī Hx of hematuria ,UTI,diabetis ,NS disease
,urinary retention, surgery ofLUT
3/28/2014AUR seminar32
34. DiagnosisâĻ.
3/28/2014AUR seminar34
ī DRE âprostate size,consistance,noduls
-pelvic floor tone flactuance &pain
- prostate size does not correlate with
symptoms severity & degree of urodynamic
obstruction & Rx outcome
ī Prostate is
large,smooth,convex,elastic,firm,mucosa
moves over the prostate
ī Ns examination (r/o cavaequina lesions)
35. Investigations
3/28/2014AUR seminar35
U/A âdipstick & /or via centrifuged sediment
for blood,bact,prot,glucos âĻ
-cytology for severe irritable symptom
-urine culture
PSA to R/o prostatic Ca which can coexist
with BPH
ī Large BPH may have slightly elevated PSA
ī PSA value >4ng/ml or DRE induration or
nodularity needs transrectal us & multiple
biopsy
ī PSA & DRE increase the detection rate of
prostate Ca over DRE alone
36. InvestigationsâĻ.
3/28/2014AUR seminar36
Serum creatinine to R/o renal insufficiency
occurs in 13% of case
īŧ BPH with RI increase the risk of post.op.
complication
with RI 25%
17% without RI
īŧ Help to evaluate the pt.with occult & progressive
renal damage secondary to silent prostatism
Postvoidal residual urine
-obtained after voiding of urine with a catheter
transabdominal us
NV= less than 5 ml (78%), less than 12ml(100%)
37. InvestigationsâĻ.
3/28/2014AUR seminar37
Pressure flow studies
-done to distinguish b/n low pressure flow rate
secondary to Boo & decompensated bladder
- Reliable if Boo not Dxed by flow rate, initial evaluation
& PVR
uroflometry
- electrical recording of the urine flow rate
-noninvasive urodynimic test
-quantifies strength of urine stream
-2 to 3 voids with voided volume 150 to 200ml in
flow rate clinic
38. 3/28/2014AUR seminar38
ī Watchful waiting: In patients with mild symptoms.
ī Medical treatment
1. Alpha reductase inhibitor: affects the epithelial component of
the prostate, resulting in reduction in the size of the gland and
improvement in symptoms.
2. Alpha-adrenoceptor blacker: affect subtype alpha-1
adrenoreceptors. (dynamic component of obstruction).
3. Combination.
ī Surgical treatment: Minimally invasive or open.
By Mohammed Ibrahim, MBBcH Revised by M.A.Wadood , MD, MRCS
TREATMENT
39. 3/28/2014AUR seminar39
A- Absolute indications:
ī Upper urinary tract
affection.
ī Uremia
ī Recurrent attacks of acute
retention.
ī Severe obstructive
symptoms (high IPSS
score).
By Mohammed Ibrahim, MBBcH Revised by M.A.Wadood , MD, MRCS
Indications of surgical intervention
B- Relative indications:
âĸ Moderate symptoms (moderate
IPSS score).
âĸ Recurrent UTI.
âĸ Hematuria.
âĸ Stone bladder.
40. 3/28/2014AUR seminar40
ī Transurethral resection of the prostate.
ī Transurethral incision of the prostate
ī Transurethral needle abelation
ī Ballon dilatation.
ī Transurethral microwave treatment.
ī Intraprostatic stents.
By Mohammed Ibrahim, MBBcH Revised by M.A.Wadood , MD, MRCS
Minimally-invasive surgery
44. ProstatectomyâĻ..
3/28/2014AUR seminar44
īļComplications
īŧBleeding -urethral catheter traction with
50ml of saline to compress the bladder neck &
prostatic fossa
-bladder irrigation to prevent clot formation
-the inflow through urethral catheter &out flow
through the suprapubic tube
-if the bleeding persist cystoscopic inspection
of the prostatic fossa &bladder neck
-if marked bleeding continue to persist âopen
re-exploration
45. ComplicationsâĻâĻ
3/28/2014AUR seminar45
īļPerforation of the bladder & prostatic capsule
(IN TURP)
īļIncontinency (if damaged external sphincter
mechanism)
īļRetrograde ejaculetion(80-90%) & impotence
(3-6% due to damage of the nerves
associated with erection)
īļBladder neck contracture
īļUrethral stricture
īļSepsis
īļDeath(0.2 to 0.3%)
46. ComplicationsâĻ.
3/28/2014AUR seminar46
īļTUR-syndrome
īŧIn 2% of all TURP
īŧDue to absorption irrigating fluid through cut
open veins
īŧCharacterized by (hyponatremia ââNa+
,HPT,nauesa& vomiting,bradicardia,visual
disturbance,mental confusion)
īŧRisk factors (gland>45gm,âresection time
>90mnt & much fluid for irrigation
īRX diuretics &correct electrolytes
47. Nephrolithiasis / urolithiasis
3/28/2014AUR seminar47
ī Stone formation in the
kidney
ī Affect about 4-15% of
population
ī Males are more
commonly affect
ī Multifactorial in etiology
56. management
3/28/2014AUR seminar56
ī Conservative
ī Adequate hydration
ī Dietary modification
ī Medical treatment of
underlying conditions
ī follow up U/S
ī Surgical
ī Indications
ī Failed expectant
treatment
ī Large stone size
ī Evidence of
obstruction
ī Presence of infection
ī Non functioning
kidney with pain and
stone
57. Surgery contâd
3/28/2014AUR seminar57
ī Minimally Invasive
I. ESWL
II. PNL( Percutaneous
nephrolithotomy)
ī Open surgery
I. Pyelolithotomy
II. Extended
pyelolithotomy
III. Nephrolithotomy
IV. Nephrectomy
58. Clinical manifestations of AUR
3/28/2014AUR seminar58
ī AUR presents as the abrupt inability to pass urine.
ī lower abdominal and/or suprapubic discomfort
ī patients are often restless, and may appear in considerable
distress
ī AUR is superimposed upon chronic urinary retention
ī Chronic urinary retention is most often painless
ī presence of hematuria, dysuria, fever, low back pain, neurologic
symptoms, or rash.
ī Younger patient age, a history of cancer or intravenous drug
abuse, and the presence of back pain or neurologic symptoms
suggest the possibility of spinal cord compression.
ī Finally, a complete list of prescribed and over the counter
medications should be obtained.
59. Physical examination
3/28/2014AUR seminar59
ī previous history of retention, prostate cancer, surgery,
radiation, or pelvic trauma.
ī Lower abdominal palpation â The urinary bladder may be
palpable, either on abdominal or rectal examination. Deep
suprapubic palpation will provoke discomfort.
ī Rectal examination â A rectal examination should be done in
both men and women, to evaluate for masses, fecal impaction,
perineal sensation, and rectal sphincter tone. A normal prostate
examination does not preclude BPH as a cause of obstruction.
ī Pelvic examination â Women with urinary retention should
have a pelvic examination.
ī Neurologic evaluation â The neurologic examination should
include assessment of strength, sensation, reflexes, and muscle
tone.
61. ACUTE MANAGEMENT
Initial management of AUR
3/28/2014AUR seminar61
ī management of acute urinary retention (AUR)
involves prompt bladder decompression
ī accomplished with urethral or suprapubic
catheterization
ī Patients who have had recent urologic surgery (eg,
radical prostatectomy or urethral reconstruction) and
develop acute retention should not have urethral
catheterization
62. Management contndâĻ
3/28/2014AUR seminar62
ī Emergency drainage
ī Emergency drainage of the bladder in acute retention may be
undertaken by:
ī Urethral catheterization
ī Suprapubic puncture ???
ī Suprapubic cystostomy.
ī Urethral catheterization or bladder puncture is usually adequate,
but
ī cystostomy may become necessary for the removal of a bladder stone
or foreign body, or for more prolonged drainage, for example after
rupture of the posterior urethra or if there is a urethral stricture with
complications
63. ī SUPRAPUBIC PUNCTURE
Bladder puncture may become necessary if urethral catheterization fails.
It is essential that the bladder is palpable if a
suprapubic puncture is to be performed
3/28/2014AUR seminar63
65. SUPRAPUBIC CYSTOSTOMY
3/28/2014AUR seminar65
īŧ The purpose of supra
pubic cystostomy is
īŧ To expose and, if
necessary, allow
exploration of the bladder
īŧ To permit insertion of a
large drainage tube,
usually a self-retaining
catheter
īŧ To allow supra pubic
drainage of a non-palpable
bladder
Infiltrate using local anesthesia .5% 1%
lidocaine with adrenaline layer by layer and
supra pubic midline incision 2cm above SP
Openrectussheathusingscissors
66. supra pubic (SP) catheter
3/28/2014AUR seminar66
ī necessary in patients with urethral stricture
disease, severe BPH.
ī abnormalities that preclude Foley catheter
placement per urethra
ī Ultrasound guidance may be indicated when
adhesions are possible from prior abdominal
surgery.
67. supra pubic (SP) catheter
contndâĻ
3/28/2014AUR seminar67
ī Suprapubic catheterization is performed under local anesthesia.
ī with steady aspiration until urine is retrieved.
ī A trocar-type suprapubic tube is then passed through a one
centimeter skin incision and
ī the catheter advanced over the trocar and sutured in place.
ī The patients undergoing SP catheterization had fewer urinary
tract infections and were less uncomfortable than those who
were treated with urethral catheters.
68. supra pubic (SP) catheter
contndâĻ
3/28/2014AUR seminar68
īŧ They Allow assessment of the patient's ability to void before
removing the catheter.
īŧ The risk of complications associated with placement, including
bowel perforation and wound infection is high in SP
īŧ females, who are expected to require long-term bladder
drainage. SP catheters prevent bladder neck and urethral
dilatation and therefore prevent urinary incontinence due to
sphincter dysfunction.
īŧ They avoid the risk of subsequent urethral stricture, a common
complication in men requiring long-term urethral catheterization
69. 3/28/2014AUR seminar69
ī Duration of catheterization â The optimal duration of catheter
management prior to a trial of voiding has been evaluated, with
some contradictory findings
ī A subsequent observational study from France of 2600 men with
AUR found that men who were catheterized for three days or
less had greater success with spontaneous voiding than men
catheterized for more than three days
70. Trial without catheter(TWOC)
3/28/2014AUR seminar70
ī involves catheter removal (usually in two to three
days) and determination if the patient can
successfully void.
ī success rates for initial TWOC have ranged from 20
to 40%.
īļ Factors that favor successful trial of void includes
ī age less than 65 years,
ī detrusor pressure greater than 35 cmH2O,
ī a drained volume of less than one liter at
catheterization,
71. SURGICAL THERAPY
3/28/2014AUR seminar71
ī definitive treatment of AUR.
ī symptomatic patients with BPH, transurethral
resection of the prostate (TURP)
ī Transurethral resection of the prostate remains
the gold standard
72. SUMMARY AND RECOMMENDATIONS
3/28/2014AUR seminar72
ī Acute urinary retention (AUR) is the most common urologic emergency,
affecting 1 in 10 men age 70 and older. Benign prostate hyperplasia
(BPH) is the most common underlying condition, but multiple etiologies
may cause AUR. Medications are frequently implicated
ī Initial management of AUR involves prompt bladder decompression. We
suggest initial treatment with a Foley urethral catheter, rather than a
suprapubic catheter
ī A suprapubic catheter may be indicated when obstruction precludes a
urethral catheter, and may be preferred in patients who are expected to
require longer term decompression.
ī
73. SUMMARY AND RECOMMENDATIONS
3/28/2014AUR seminar73
ī Hospitalization is indicated for patients who are uro septic, or who have
obstruction related to malignancy or spinal cord compression.
ī Emergency surgery for relief of prostatic obstruction is rarely indicated, and
carries an increased risk over elective surgery. The majority of patients can be
managed as outpatients once bladder decompression is accomplished.
ī Removal of the catheter after a period of time ("trial without catheter" or TWOC)
results in successful spontaneous micturition in up to 40 percent of patients with
AUR, though recurrent AUR is common.
ī We suggest a trial of catheter removal in one to two weeks
ī The majority of men who have BPH and AUR will ultimately require definitive
intervention for their BPH.
ī